Efficacies of Different Managements in Patients With Trigger Finger
Comparing the Effectiveness of Peritendinous Steroid Injection Under Ultrasound Guidance With Percutaneous A1 Pulley Release in Trigger Finger Treatment
1 other identifier
observational
30
1 country
1
Brief Summary
The aim of the study is to compare the effectiveness of peritendinous steroid injection under ultrasound guidance and percutaneous A1 pulley release procedures in terms of disease stage, pain, and severity of locking in patients with trigger finger.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2023
CompletedFirst Submitted
Initial submission to the registry
April 8, 2024
CompletedFirst Posted
Study publicly available on registry
April 24, 2024
CompletedJune 6, 2024
June 1, 2024
9 months
April 8, 2024
June 5, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Stage of the disease
Modified Quinnel classification Stage 1: Normal movement, no pain. * Stage 2: Normal movement, occasional pain. * Stage 3: Irregular movement (catching without crepitus or locking). * Stage 4: Locking present, actively correctable. * Stage 5: Locking present, passively correctable.
first week, first mount, third month
Secondary Outcomes (2)
Pain intensity
first week, first month, third month
severity of triggering
first week, first month, third month
Study Arms (2)
The peritendinous steroid group
A 1 ml mixture of corticosteroid (2 mg + 5 mg/ml betamethasone) and 1 ml of local anesthetic agent (20 ml 2% prilocaine) was injected peritendinously between the A1 pulley and the flexor tendon sheath at the metacarpophalangeal joint level under ultrasound guidance.
The percutaneous A1 pulley release group
In the A1 pulley release group, 1 ml of local anesthetic agent (20 ml 2% prilocaine) was injected into the pulley-associated subcutaneous tissue using a 27 G needle under ultrasound guidance. The metacarpophalangeal joint was brought into slight hyperextension. Subsequently, a 20 G 0.9x38mm needle, modified by bending approximately 40-45 degrees from the proximal 1/3 of the needle with the aid of a cap, was used. The needle was advanced in-plane from distal to proximal along the midline, with simultaneous movement towards the palmar surface, aiming to cut or loosen the pulley between the tendon and A1 pulley. The loosening procedure was repeated from the distal to proximal aspect of the pulley until the sensation of resistance at the needle tip disappeared.
Interventions
Ultrasound-guided percutaneous pulley release is a procedure aimed at loosening the pulley using various cutting instruments or hypodermic needles under ultrasound guidance.
USG-guided injection of corticosteroid between the A1 pulley and the flexor tendon sheath.
Eligibility Criteria
older 18 ages
You may qualify if:
- Being over 18 years of age
- Having had trigger finger complaints for more than 1 month
- Not having received any injections for trigger finger diagnosis within the last 1 month
- Signing the informed consent form indicating willingness to participate in the study
You may not qualify if:
- Refusing to participate in the study
- Presence of partial or complete tendon rupture in the relevant tendon of the finger to be treated
- Presence of wounds and infection in the area where the procedure will be performed
- Pregnancy status
- History of allergy to the injected medications (local anesthetic, steroid)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziler Physical Medicine and Rehabilitation Education and Research Hospital
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
zeliha gizem mac, MD
university of health sciences, Department of PM&R
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
April 8, 2024
First Posted
April 24, 2024
Study Start
October 1, 2022
Primary Completion
June 30, 2023
Study Completion
June 30, 2023
Last Updated
June 6, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share